Vantage Investment Partners LLC cut its holdings in shares of Cardinal Health Inc (NYSE:CAH) by 97.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,486 shares of the company’s stock after selling 157,684 shares during the period. Vantage Investment Partners LLC’s holdings in Cardinal Health were worth $274,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. Steward Partners Investment Advisory LLC acquired a new stake in shares of Cardinal Health in the 3rd quarter valued at approximately $102,000. Ffcm LLC acquired a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $105,000. JNBA Financial Advisors raised its position in shares of Cardinal Health by 615.4% in the 4th quarter. JNBA Financial Advisors now owns 1,860 shares of the company’s stock valued at $114,000 after acquiring an additional 1,600 shares during the period. Cerebellum GP LLC acquired a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $129,000. Finally, James Hambro & Partners acquired a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $138,000. Institutional investors own 88.65% of the company’s stock.
A number of analysts recently weighed in on the stock. Barclays assumed coverage on shares of Cardinal Health in a research report on Thursday. They issued an “equal weight” rating and a $74.00 price target on the stock. Zacks Investment Research downgraded shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Wednesday. Bank of America assumed coverage on shares of Cardinal Health in a research report on Tuesday, February 27th. They issued an “underperform” rating and a $69.00 price target on the stock. Evercore ISI assumed coverage on shares of Cardinal Health in a research report on Thursday, January 4th. They issued an “in-line” rating and a $67.00 price target on the stock. Finally, ValuEngine downgraded shares of Cardinal Health from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Three equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have given a buy rating to the company’s stock. Cardinal Health presently has a consensus rating of “Hold” and an average target price of $74.78.
Shares of Cardinal Health Inc (CAH) opened at $71.16 on Friday. Cardinal Health Inc has a 52 week low of $54.66 and a 52 week high of $84.88. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.57 and a current ratio of 1.09. The stock has a market capitalization of $22,394.55, a P/E ratio of 12.38, a P/E/G ratio of 1.60 and a beta of 0.95.
Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, February 8th. The company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.14 by $0.17. Cardinal Health had a return on equity of 24.81% and a net margin of 1.37%. The business had revenue of $35.19 billion during the quarter, compared to analysts’ expectations of $34.63 billion. During the same period in the prior year, the business earned $1.34 EPS. Cardinal Health’s revenue for the quarter was up 6.1% compared to the same quarter last year. analysts anticipate that Cardinal Health Inc will post 5.42 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Sunday, April 15th. Stockholders of record on Monday, April 2nd will be paid a dividend of $0.4624 per share. The ex-dividend date is Thursday, March 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.60%. Cardinal Health’s dividend payout ratio is currently 32.17%.
Cardinal Health declared that its Board of Directors has authorized a stock repurchase program on Thursday, February 8th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback programs are often a sign that the company’s leadership believes its shares are undervalued.
COPYRIGHT VIOLATION WARNING: “Vantage Investment Partners LLC Cuts Holdings in Cardinal Health Inc (CAH)” was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://sportsperspectives.com/2018/03/11/vantage-investment-partners-llc-cuts-holdings-in-cardinal-health-inc-cah.html.
Cardinal Health Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.